glp-1 drugs differences Natural Support: Why Microbiome Repair Matters Mounjaro and Ozempic are NOT

The impact of the drugs is not confined to the food and dieting industry

Some GLP-1 medications have demonstrated cardiovascular protective effects in specific populationsliraglutide, semaglutide injection, and dulaglutide have shown cardiovascular outcome benefits, with Wegovy (semaglutide) recently receiving an FDA indication for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity

Overall, while GLP-1RAs may offer metabolic benefits in PCOS management, the increased risk of nausea and dizziness should be carefully considered in clinical practice 33

In other words, a hypothetical unmeasured confounder could substantially bias our results only if it was both highly imbalanced between the exposure groups and strongly associated with the outcome

But here is the critical detail

The recommended starting dosage for Mounjaro is 2.5 mg once a week